Authors' recommendations: There is low quality evidence suggesting that gadoxetic acid-enhanced MRI might have a similar performance to that of multidetector CT scan in diagnosing hepatocarcinoma and to that of diffusion-weighted MRI in liver metastasis for colorectal cancer detection. It might have a better diagnostic performance than those technologies in lesions less than 1 centimeter. In the case of colorectal cancer metastasis, the combination of diffusion-weighted MRI and gadoxetic acid-enhanced MRI would increase sensitivity although its performance is not very clear when compared with CT scan. Low quality evidence indicates the technology has adequate sensitivity and specificity to differentiate focal nodular hyperplasia from hepatocellular carcinoma. Most current clinical practice guidelines recommend its use to diagnose hepatocarcinoma and liver metastasis from colorectal cancer as an alternative to multidetector CT scan and to other types of magnetic resonance imaging, as well as to differentiate focal nodular hyperplasia from hepatocellular adenoma.

Project Status: Completed

Year Published: 2017

URL for published report: www.iecs.org.ar/home-ets/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Argentina

Organisation Name: Institute for Clinical Effectiveness and Health Policy

Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA

Contact Name: info@iecs.org.ar

Contact Email: info@iecs.org.ar

Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)